Results 21 to 30 of about 2,262,684 (231)

Nephrogenic diabetes insipidus with idiopathic Fanconi′s syndrome in a child who presented as vitamin D resistant rickets

Indian Journal of Endocrinology and Metabolism, 2011
Fanconi′s syndrome is a complex of multiple tubular dysfunctions of proximal tubular cells occurring alone or in association with a variety of inherited (primary) or acquired (secondary) disorders.
Soumya Patra, Gulnaz Nadri, Harish Chowdhary, Harish K Pemde, Varinder Singh, Jagdish Chandra   +5 more
doaj   +2 more sources

Adefovir-induced Fanconi syndrome associated with osteomalacia [PDF]

Clinical and Molecular Hepatology, 2018
Fanconi syndrome is a dysfunction of the proximal renal tubules that results in impaired reabsorption and increased urinary loss of phosphate and other solutes. The pathophysiology of drug-induced Fanconi syndrome is unclear. Here we report the case of a
Samel Park, Woo-Il Kim, Dai-Hyun Cho, Yeo-Joo Kim, Hong-Soo Kim, Ji-Hee Kim, Seung-Kuy Cha, Kyu-Sang Park, Ji-Hye Lee, Sang Mi Lee, Eun Young Lee   +10 more
doaj   +2 more sources

Fanconi syndrome and renal tubular necrosis in patients following ingestion of potentially contaminated red yeast rice supplement: Two case reports [PDF]

Physiological Reports
We present two cases of middle‐aged men who developed Fanconi syndrome and renal dysfunction after consuming “foods with functional claims (FFC)” containing red yeast rice.
Yoshiyuki Yoshikawa, Hitoshi Anzai, Kohei Odajima, Shinichiro Asakawa, Shigeyuki Arai, Osamu Yamazaki, Yoshifuru Tamura, Ryuji Ohashi, Shigeru Shibata, Yoshihide Fujigaki   +9 more
doaj   +2 more sources

Tubular damage and SGLT2 expression in a patient with Beni-koji tablet-associated acute kidney injury and Fanconi syndrome. [PDF]

CEN Case Rep
Kamada A, Hirose T, Hashimoto H, Konya Y, Sato F, Ishiyama K, Joh K, Yumura W, Mori T.   +8 more
europepmc   +3 more sources

A case of Fanconi syndrome that developed following a year of consumption of a red yeast rice supplement. [PDF]

CEN Case Rep
Kawai Y, Ozawa M, Isomura A, Mitsuhashi H, Yamaguchi S, Nagayama S, Tanaka S, Abe E, Saka S, Nagahama K, Iwamoto T, Tamura K.   +11 more
europepmc   +2 more sources

Correction to: A case of acute kidney injury and Fanconi syndrome while taking multiple supplements, including Red Yeast Rice Cholesterol Help^®. [PDF]

CEN Case Rep
Oda K, Murata T, Tanaka F, Oda H, Tsujimoto K, Fukumori A, Yamawaki M, Saiki R, Suzuki Y, Katayama K, Dohi K.   +10 more
europepmc   +3 more sources

Correction to: Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: a case report. [PDF]

CEN Case Rep
Kita Y, Shirai S, Koyama T, Makinouchi R, Machida S, Matsui K, Koike J, Imai N.   +7 more
europepmc   +3 more sources

Fanconi syndrome and euglycemic diabetic ketoacidosis secondary to canagliflozin use in a type 2 diabetic

Journal of Clinical and Translational Endocrinology Case Reports, 2022
Use of sodium glucose cotransporter 2 (SGLT2) inhibitors is increasing for management of type 2 diabetes, congestive heart failure, and chronic kidney disease.
Nicholas Arlas, Jeremy W. Vandiver
doaj   +1 more source

Fanconi syndrome-associated interstitial lung disease. [PDF]

BMJ Case Rep, 2022
Papaioannou O, Karampitsakos T, Sampsonas F, Tzouvelekis A.   +3 more
europepmc   +3 more sources

Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector. [PDF]

, 2010
One of the major hurdles for the development of gene therapy for Fanconi anemia (FA) is the increased sensitivity of FA stem cells to free radical-induced DNA damage during ex vivo culture and manipulation.
Adair, J, Beard, BC, Becker, PS, Chien, S, Kiem, H-P, Kohn, DB, Shimamura, A, Taylor, JA, Trobridge, GD, Wagner, JE, Zhao, X   +10 more
core   +5 more sources